Communication professional at Roche. Tweets are my own and do not represent the vision of my employer.
Basel, Switzerland
Joined May 2011
- Tweets215
- Following251
- Followers166
- Likes16
Nancy Nackaerts retweeted
Gute Nachricht: @Swissmedic_ hat den ersten #COVID19-Impfstoff zugelassen. Er hat sich als wirksam, sicher und qualitativ einwandfrei erwiesen. In den nächsten Tagen wird mit dem Impfen begonnen. Die #Impfung ist kostenlos – und wird sehr empfohlen. #CoronaInfoCH @BAG_OFSP_UFSP – at Berne, Switzerland
Nancy Nackaerts retweeted
There are few people I’ve learned more from over the years–especially about viruses–than Peter Piot. This Q&A with him is an excellent, easy-to-understand primer on #COVID19: b-gat.es/3bBcIyC
Nancy Nackaerts retweeted
For those of us who wish we could be in two places at once: there’s hope for us yet 😉scientificamerican.com/artic…
Nancy Nackaerts retweeted
How do you value and pay for a one-time treatment that provides a lifetime of benefits? My thoughts on @CNBC: cnb.cx/2HtziwN
@Novartis @cnbcevents
Nancy Nackaerts retweeted
Patient groups ranked us #4 in @PatientView’s 2018 Reputation Report. We’ve made great progress over the past year in building our capabilities to better embed patient perspectives in our work and we want to progress further. #OurCommitment bit.ly/2ZRSqLV
Nancy Nackaerts retweeted
Horrifyingly brilliant! m.youtube.com/watch?v=6sGH_v… – at Basel, Switzerland
Nancy Nackaerts retweeted
Behind the scenes at our new ‘control tower’ to track, analyse and predict the status of all our clinical studies. 500+ active trials, 70+ countries, 80 000+ patients - transformative for how we develop medicines.
Nancy Nackaerts retweeted
“We need our teams to think about access early on. It’s not enough to develop an innovative medicine if there is no way for people to actually get access to it.” Patrice Matchaba @Novartis #AccessinAction
Nancy Nackaerts retweeted
“Malaria is very complex, and technology like AI can help determine the right mix of interventions, and how to deploy them to reach the right patients.” David Reddy from @medsformalaria #AccessinAction
Nancy Nackaerts retweeted
“We don’t need solutions. We need transformations.” Says @myblueeconomy #AccessinAction
Nancy Nackaerts retweeted
#accessinaction The importance of heart to heart communication. To become a supplier of a factory you need to plant a plant in the roof. It’s not time for protesting, it’s time to join strengths to change reality.@NovartisSpain @Novartis @gunterpauli
Nancy Nackaerts retweeted
#2 worldwide - still more work to do, but we are on the right track. Breakthrough innovation needs an environment where differences are valued, people can think differently and diverse ideas are heard. @Novartis tmsnrt.rs/2PBG9Fq
How we’re moving boldly toward transformative innovation linkedin.com/pulse/how-were-…
1
Nancy Nackaerts retweeted
Only patients can tell us what it is like to live with a disease and what they need from a treatment. I’m pleased our efforts to listen to those insights are being felt. #OurCommitment xitter.cf/Novartis/status/981925…
.@PatientView’s 2017 Reputation Report ranked Novartis #4, underlining our continued commitment to incorporate patient perspectives in our research, development and commercial activities. #OurCommitment
Nancy Nackaerts retweeted
Thanks to @ideapharma for recognizing our work with a #3 ranking in their Pharmaceutical Innovation Index. We’re inspired every day to bring truly innovative medicines to people worldwide. bit.ly/2GSWFhj
Nancy Nackaerts retweeted
Very proud @Novartis named among world’s most innovative companies by @FastCompany. Our people are helping deliver an explosion of innovation in medical science #reimaginemedicine xitter.cf/Novartis/status/965922…
.@FastCompany has just named us #1 most innovative #biotech company & #21 across all industries. Here’s why: bit.ly/2oigQMI #ReimagineMedicine #NovartisNews
Nancy Nackaerts retweeted
.@FastCompany has just named us #1 most innovative #biotech company & #21 across all industries. Here’s why: bit.ly/2oigQMI #ReimagineMedicine #NovartisNews